Product information and disease descriptionProduct descriptionProduct informationPharmacology
Pharmacokinetics
7 evidence topics · 3 sources
Route: delivery into cerebrospinal fluid and systemic exposure
“Delivery of recombinant adeno-associated virus serotype 9 (rAAV9) into cerebrospinal fluid bypasses the blood–brain barrier and can permit efficient brain tissue transduction.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“As with intracisterna magna (ICM) or intra-cerebroventricular (ICV) instillation, IT delivery bypasses the blood–brain barrier, reduces vector load in systemic circulation, and minimizes risk of interference of pre-existing anti-AAV antibodies” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Uniquely, it offers the possibility of outpatient treatment with no specialized surgical equipment.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Biodistribution of TSHA-102 in nonhuman primate brain and spinal cord after lumbar intrathecal infusion
“CNS biodistribution showed generally similar vector genome levels in all CNS tissues tested, with a low value observed at the 90-day point for the cervical spinal cord” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Across four NHP biodistribution studies, at times ranging from 1 month to 1 year post-treatment, lumbar IT administration led to widespread, stable, and generally uniform vector genome levels throughout the brain and spinal cord.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Across five NHP biodistribution studies, rAAV9 DNA was quantifiable in all brain and CNS tissues examined, irrespective of RoA (IT versus ICM) or time post-necropsy, at typical levels exceeding 1 vg copy per brain cell at the highest doses.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Comparison of lumbar intrathecal and intracisterna magna delivery
“At comparable doses and times, IT and ICM delivery led to widespread and consistent distribution of vector genomes, approximating 1 vg/diploid host genome throughout the brain at the higher doses tested.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The ratio of ICM to lumbar IT vector biodistribution in various brain and spinal cord tissues ranged from <1 (temporal lobe) to ~5 (cerebellum).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Dose dependence and change over time in brain vector genome levels
“Comparing TSHA-102 versus TSHA-105 data, both with lumbar IT delivery, the four-fold increase in input dose with TSHA-105 was associated with a ~2.5-fold increase in vector genome levels detected in brain tissues; this difference was seen at both necropsy time points.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This analysis also indicated higher brain vector genome levels in Day ≥180 necropsy samples, relative to Day 90 samples, in animals that had been treated by lumbar IT dosing.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Limitations reported for the lumbar intrathecal route
“However, some studies have suggested the lumbar IT route leads to limited transduction of brain tissues” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The fact that these studies were conducted separately, according to different protocols, limits the precision of any quantitative claims that can be made for rAAV9 biodistribution from this data set” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Administration and monitoring conditions of the nonclinical biodistribution studies
“IT injection was to the L4-5 or L5-6 intervertebral space, with the needle tip angled slightly cranially.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Injections (2.5 mL total volume) were performed with animals prone or recumbent, not in the Trendelenburg position.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“No immunosuppression was used.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Detection of vector DNA in all tissues analyzed at 90 and 180 days
Pharmacokinetic measurements in humans
No evidence found.